Posted by M.Popov on 12th Nov 2020
Trial size ALDH3A1 antibodies available in the Antibody Validation Project
Trial size ALDH3A1 antibodies available in the Antibody Validation Project
Introduction:
Aldehyde dehydrogenase 3 family member A1(more commonly known as ALDH3A1 protein) takes part in the oxidation of various aldehydes, which are involved in the metabolism of corticosteroids and lipid peroxidation. The enzyme that is encoded can be used for very specific tests, because of its target group of substrates that it oxidises. We provide a number of trial sized antibodies, which are suitable for ALDH3A1 research purposes, and to help you make the right decision and find the best suited antibody for you, please find the answers to some of the key topics regarding ALDH3A1 that we have provided in the links below.
- What is ALDH3A1?
- Where is ALDH3A1 found?
- What role does ALDH3A1 play in disease?
- ALDH3A1 antibodies in the Antibody Validation project
- Customer reviewed ALDH3A1 antibodies
- Other ALDH3A1 antibodies available in the Antibody Validation Project
- Popular ALDH3A1 antibodies not currently in the Antibody Validation Project
- How does the Antibody Validation Project work?
What is ALDH3A1?
ALDH3A1 oxidises various aldehydes to the corresponding acids. Aldehyde dehydrogenases are involved in the detoxification of alcohol-derived acetaldehyde and in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. The enzyme encoded by this gene forms a cytoplasmic homodimer that preferentially oxidizes aromatic and medium-chain (6 carbons or more) saturated and unsaturated aldehyde substrates. It is thought to promote resistance to UV and 4-hydroxy-2-nonenal-induced oxidative damage in the cornea.
Where is ALDH3A1 found?
ALDH3A1 is mainly found in the cytoplasm, squamous epithelia, and in several tissues in humans, mainly in esophagus, tongue, stomach and lymphoid tissue.
What role does ALDH3A1 play in disease?
ALDH3A1 is present in higher levels in breast and lung tumours, and also is a prognostic marker in head and neck cancer(favourable).
ALDH3A1 antibodies in the Antibody Validation project
St John's Laboratory offers a variety of trial size primary antibodies which target ALDH3A1, which are available to try through the Antibody Validation Project. Below we highlight those which have already been reviewed, as well as others which are available to try.
Customer reviewed ALDH3A1 antibodies
| Model | Name | Host | Clonality | Rating | Application Tested |
|---|---|---|---|---|---|
| STJ96390 | ALDH3A1 | Rabbit | Polyclonal | 4 | WB |
Other ALDH3A1 antibodies available in the Antibody Validation Project
Currently we do not have any other ALDH3A1 antibodies available in the AVP.
Popular ALDH3A1 antibodies not currently in the Antibody Validation Project
| Model | Name | Host | Clonality | Recommended Applications | ||
|---|---|---|---|---|---|---|
| STJ115240 | Anti-ALDH3A1 Antibody | Rabbit | Polyclonal | WB,IHC,IF | ||
| STJ27453 | Anti-ALDH3A1 Antibody | Rabbit | Polyclonal | WB,IF | ||
| STJ72273 | Anti-ALDH3A1 Antibody | Goat | Polyclonal | ELISA,WB,IHC |
How does the Antibody Validation Project work?
In order to help our customers with their choice of antibody with low risk, we offer one of the largest ranges of primary antibodies with trial size options available.
The Antibody Validation Project works like this.
1. Order your trial size antibody online.
2. Explore its suitability.
3. Return your results by posting them on the product page.
4. Receive a sample refund.
Find out more here.